It is common to treat community-acquired pneumonia in children with 10 days of high-dose amoxicillin; however, data from the Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia (SAFER) trial suggest that 5 days may be adequate.
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
ACIP recommends PCV20 alone or PCV15 in series with PPSV23 for all aged 65 years and older or younger adults at risk.
The randomized, double-blind, placebo-controlled study included a total of 380 patients aged 6 to 71 months with nonsevere CAP.
What dosage of dexamethasone most effectively improves outcomes in patients hospitalized with moderate or severe COVID-19 pneumonia?
The most physically active groups in the general population had lower risk for incident pneumonia and pneumonia-related mortality.
Exposure to PM2.5 above 10.75 µg/m3 associated with residence in area with high risk for community-acquired pneumonia in children.
The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.
Amoxicillin unlikely to be clinically effective overall or in specified clinical subgroups in whom antibiotics are commonly prescribed.
Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine.
